Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: A Study to Evaluate Solrikitug in Participants With COPD (ZION) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Solrikitug in adults with chronic obstructive pulmonary disease (COPD) is currently recruiting under the ZION trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solrikitug

Snippet

Sponsor: Uniquity One (UNI) | Conditions: COPD | Phase 2 | Status: RECRUITING